Protein kinase B regulates T lymphocyte survival, nuclear factor κB activation, and Bcl-X(L) levels in vivo

Journal of Experimental Medicine

Volumn 191, Issue 10, 2000, Pages 1721-1733

  Jones, Russell G ^a   Parsons, Michael ^a   Bonnard, Madeleine ^b   Chan, Vera S F ^a   Yeh, Wen Chen ^a,b   Woodgett, James R ^a   Ohashi, Pamela S ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b AMGEN INSTITUTE   (Canada)

Author keywords

Apoptosis; Bcl X(L); NF B; PKB Akt; Thymocyte selection

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; MOUSE; NONHUMAN; ORGAN CULTURE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; THYMOCYTE; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; BCL-X PROTEIN; CELL SURVIVAL; DNA-BINDING PROTEINS; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; GENES, GAG; HUMANS; I-KAPPA B PROTEINS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; NF-KAPPA B; PREGNANCY; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; T-LYMPHOCYTES;

EID: 0034658320     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.191.10.1721     Document Type: Article

References (76)

1. Sebzda, E., S. Mariathasan, T. Ohteki, R. Jones, M.F. Bachmann, and P.S. Ohashi. 1999. Selection of the T cell repertoire. Annu. Rev. Immunol. 17:829-874.
2. + T cells, but affect their long-term life span. Immunity. 5:217-228.
3. Tanchot, C., F.A. Lemonnier, B. Pérarnau, A.A. Freitas, and B. Rocha. 1997. Differential requirements for survival and proliferation of CD8 naive or memory T cells. Science. 276: 2057-2062.
4. Kirberg, J., A. Berns, and H. von Boehmer. 1997. Peripheral T cell survival requires continual ligation of the T cell receptor to major histocompatibility complex-encoded molecules. J. Exp. Med. 186:1269-1275.
5. Lenardo, M.J., F.K.M. Chan, F. Hornung, H. McFarland, R. Siegel, J. Wang, and L. Zheng. 1999. Mature T lymphocyte apoptosis-imnuitie regulation in a dynamic and unpredictable environment. Annu. Rev. Immunol. 17:221-253.
6. L. Immunity. 3:87-98.
7. Radvanyi, L., Y. Shi, H. Vaziri, A. Sharma, R. Dhala, G.B. Mills, and R.G. Miller. 1996. CD28 costimulation inhibits TCR-induced apoptosis during a primary T cell response. J. Immunol. 156:1788-1798.
8. Vella, A.T., T. Mitchell, B. Groth, P.S. Linsley, J.M. Green, C.B. Thompson, J.W. Kappler, and P. Marrack. 1997. CD28 engagement and proinflammatory cytokines contribute to T cell expansion and long-term survival in vivo. J. Immunol. 158:4714-4720.
9. Rathmell, J.C., and C.B. Thompson. 1999. The central effectors of cell death in the immune system. Annu. Rev. Immunol. 17:781-828.
10. Sentman, C.L., J.R. Shutter, D. Hockenbery, O. Kanagawa, and S.J. Korsmeyer. 1991. Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell. 67: 879-888.
11. Strasser, A., A.W. Harris, and S. Cory. 1991. Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell. 67:889-899.
12. L and Bcl-2 repress a common pathway of cell death. J. Exp. Med. 182:821-828.
13. Grillot, D.A., R. Merino, and G. Nunez. 1995. Bcl-XL displays restricted distribution during T cell development and inhibits multiple forms of apoptosis but not clonal deletion in transgenic mice. J. Exp. Med. 182:1973-1983.
14. Williams, O., T. Norton, M. Halligey, D. Kioussis, and H.J.M. Brady. 1998. The action of Bax and Bcl-2 on T cell selection. J. Exp. Med. 188:1125-1133.
15. Mok, C., G. Gil-Gomez, O. Williams, M. Coles, S. Taga, M. Tolaini, T. Norton, D. Kioussis, and H.J.M. Brady. 1999. Bad can act as a key regulator of T cell apoptosis and T cell development. J. Exp. Med. 189:575-586.
16. Coffer, P.J., J. Jin, and J.R. Woodgett. 1998. Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem. J. 335:1-13.
17. Datta, S.R., A. Brunet, and M.E. Greenberg. 1999. Cellular survival: a play in three Akts. Genes Dev. 13:2905-2927.
18. Alessi, D.R., and P. Cohen. 1998. Mechanism of activation and function of protein kinase B. Curr. Opin. Gen. Dev. 8:55-62.
19. Datta, S.R., H. Dudek, X. Tao, S. Masters, H. Fu, Y. Gotoh, and M.E. Greenberg. 1997. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 91:231-241.
20. del Peso, L., M. Gonzalez-Garcia, C. Page, R. Herrera, and G. Nunez. 1997. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science. 278:687-689.
21. Cardone, M.H., N. Roy, H.R. Stennicke, G.S. Salvesen, T.F. Franke, E. Stanbridge, S. Frisch, and J.C. Reed. 1998. Regulation of cell death protease caspase-9 by phosphorylation. Science. 282:1318-1321.
22. Paradis, S. and G. Ruvkun. 1998. Caenorhabitis elegans Akt/ PKB transduces insulin receptor-like signals from AGE-1 P13 kinase to the DAF-16 transcription factor. Genes Dev. 12: 2488-2498.
23. Brunet, A., A. Bonni, M.J. Zigmond, M.Z. Lin, P. Juo, L.S. Hu, M.J. Anderson, K.C. Arden, J. Blenis, and M.E. Greenberg. 1999. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell. 96:857-868.
24. Biggs, W.H. III, J. Meisenhelder, T. Hunter, W.K. Cavenee, and K.C. Arden. 1999. Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc. Natl. Acad. Sci. USA. 96: 7421-7426.
25. Kops, G.J.P., N.D. de Ruiter, A.M.M. de Vries-Smits, D.R. Powell, J.L. Bos, and B.M. Burgering. 1999. Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature. 398:630-634.
26. Romashkova, J.A., and S.S. Makarov. 1999. NF-κB is a target of Akt in anti-apoptotic PDGF signalling. Nature. 401: 86-89.
27. Ozes, O.N., L.D. Mayo, J.A. Gustin, S.R. Pfeffer, L.M. Pfeffer, and D.B. Donner. 1999. NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature. 401:82-85.
28. Kane, L.P., V.S. Shapiro, D. Stokoe, and A. Weiss. 1999. Induction of NF-κB by the Akt/PKB kinase. Curr. Biol. 9:601-604.
29. Burgering, B.M., and P.J. Coffer. 1995. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature. 376:599-602.
30. Zhumabekov, T., P. Corbella, M. Tolaini, and D. Kioussis. 1995. Improved version of a human CD2 minigene based vector for T cell-specific expression in transgenic mice. J. Immunol. Methods. 185:133-140.
31. Pircher, H., K. Bürki, R. Lang, H. Hengartner, and R. Zinkernagel. 1989. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature. 342: 559-561.
32. Kayagaki, N., N. Yamaguchi, F. Nagao, S. Matsuo, H. Maeda, K. Okumura, and H. Yagita. 1997. Polymorphism of murine Fas ligand that affects the biological activity. Proc. Natl. Acad. Sci. USA. 94:3914-3919.
33. Sebzda, E., T.M. Kündig, C.T. Thomson, K. Aoki, S.Y. Mak, J. Mayer, T.M. Zamborelli, S. Nathenson, and P.S. Ohashi. 1996. Mature T cell reactivity altered by a peptide agonist that induces positive selection. J. Exp. Med. 183: 1093-1104.
34. Schmid, I., C.H. Uittenbogaart, and J.V. Giorgi. 1994. Sensitive method for measuring apoptosis and cell surface phenotype in human thymocytes by flow cytometry. Cytometry. 15: 12-20.
35. Pfeffer, K., T. Matsuyama, T.M. Kündig, A. Wakeham, K. Kishihara, A. Shahinian, K. Wiegmann, P.S. Ohashi, M. Krönke, and T.W. Mak. 1993. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L monocytogenes infection. Cell. 73:456-467.
36. Bellacosa, A., J.R. Testa, S.P. Staal, and P.N. Tsichlis. 1991. A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science. 254:274-277.
37. Henderson, L.E., H.C. Krutzsch, and S. Oroszlan. 1983. Myristyl amino-terminal acylation of murine retrovirus proteins: an unusual post-translational proteins modification. Proc. Natl. Acad. Sci. USA. 80:339-343.
38. Schultz, A.M., and S. Oroszlan. 1983. In vivo modification of retroviral gag gene-encoded polyproteins by myristic acid. J. Virol. 46:355-361.
39. Ahmed, N.N., T.F. Franke, A. Bellacosa, K. Datta, M.E. Gonzalez-Portal, T. Taguchi, J.R. Testa, and P.N. Tsichlis. 1993. The proteins encoded by c-akt and v-akt differ in post-translational modification, subcellular localization and oncogenic potential. Oncogene. 8:1957-1963.
40. Staal, S.P. and J.W. Hartley. 1988. Thymic lymphoma induction by the AKT8 murine retrovirus. J. Exp. Med. 167:1259-1264.
41. Stambolic, V., A. Suzuki, J.L. de la Pompa, G.M. Brothers, G. Mirtsos, T. Sasaki, J. Ruland, J.M. Penninger, D.P. Siderovski, and T.W. Mak. 1998. Negative regulation of PKB/ Akt-dependent cell survival by the tumor suppressor PTEN. Cell. 95:29-39.
42. Hausler, P., G. Papoff, A. Eramo, K. Reif, D. Cantrell, and G. Ruberti. 1998. Protection of CD95-mediated apoptosis by activation of phosphatidylinositide 3-kinase and protein kinase B. Eur. J. Immunol. 28:57-69.
43. Konvalinka, J., A.M. Heuser, O. Hruskova-Heidingsfeldova, V.M. Vogt, J. Sedlacek, P. Strop, and H.G. Krausslich. 1995. Proteolytic processing of particle-associated retroviral polyproteins by homologous and heterologous viral proteinases. Eur. J. Biochem. 228:191-198.
44. Sebzda, E., V.A. Wallace, J. Mayer, R.S.M. Yeung, T.W. Mak, and P.S. Ohashi. 1994. Positive and negative thymocyte selection induced by different concentrations of a single peptide. Science. 263:1615-1618.
45. + stage during positive selection and promotes thymocyte differentiation at several control points. Immunity. 1:197-205.
46. + thymocytes is altered by overexpression of the BCL-2 protooncogene in the thymus. J. Exp. Med. 179:145-153.
47. Motoyama, N., F. Wang, K.A. Roth, H. Sawa, K. Nakayama, I. Negishi, S. Senju, Q. Zhang, S. Fujii, and D.Y. Loh. 1995. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science. 267:1506-1.510.
48. Ma, A., J.C. Pena, B. Chang, E. Margosian, L. Davidson, F.W. Alt, and C.B. Thompson. 1995. Bclx regulates the survival of double-positive thymocytes. Proc. Natl. Acad. Sci. USA. 92:4763-4767.
49. Okada, T., L. Sakuma, Y. Fukui, O. Hazeki, and M. Ui. 1994. Blockage of chemotactic peptide-induced stimulation of neutrophils by wortmannin as a result of selective inhibition of phosphatidylinositol 3-kinase. J. Biol. Chem. 269:3563-3567.
50. Veis, D.J., C.L. Sentman, E.A. Bach, and S.J. Korsmeyer. 1993. Expression of the bcl-2 protein in murine and human thymocytes and in peripheral T lymphocytes. J. Immunol. 151:2546-2554.
51. L Cell. 87:619-628.
52. Baldwin, A.S., Jr. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649-683.
53. Peter, M.E., F.C. Kischkel, C.G. Scheuerpflug, J.P. Medema, K.-M. Debatin, and P.M. Krammer. 1997. Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLlCE (MACH/caspase 8) to the CD95 death-inducing signaling complex. Eur. J. Inmunol. 27:1207-1212.
54. l acts downstream of caspase-8 activation by the CD95 death-inducing signaling complex. J. Biol. Chem. 273: 3388-3393.
55. Strasser, A., A.W. Harris, D.C.S. Huang, P.H. Krammer, and S. Cory. 1995. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO (Eur. Mol. Biol. Organ.) J. 14:6136-6147.
56. Scaffidi, C., S. Fulda, A. Srinivasan, C. Friesen, F. Li, K.J. Tomaselli, K.-M. Debatin, P.H. Krammer, and M.E. Peter. 1998. Two CD95 (APO-1/Fas) signaling pathways. EMBO (Eur. Mol. Biol. Organ.) J. 17:1675-1687.
57. Scaffidi, C., I. Sdimitz, J. Zha, S.J. Korsmeyer, P.H. Krammer, and M.E. Peter. 1999. Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. J. Biol. Chem. 274:22532-22538.
58. Gratiot-Deans, J., R. Merino, G. Nunez, and L.A. Turka. 1994. Bcl-2 expression during T-cell development: early loss and late return occur at specific stages of commitment to differentiation and survival. Proc. Natl. Acad. Sci. USA. 91: 10685-10689.
59. L interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. Proc. Natl. Acad. Sci. USA. 95:4386-4391.
60. L, and Apaf-1 form a ternary complex. J. Biol. Chem. 273:5841-5845.
61. Muzio, M., A.M. Chinnaiyan, F.C. Koschkel, K. O'Rourke, A. Shevchenko, J. Ni, C. Scaffidi, J.D. Bretz, M. Zhang, R. Gentz, et al. 1996. FLICE, a novel FADD-homologous ICE/ CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell. 85:817-827.
62. Kischkel, F.C., S. Hellbardt, I. Behrmann, M. Germer, M. Pawlita, P.H. Krammer, and M.E. Peter. 1995. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO (Eur. Mol. Biol. Organ.) J. 14:5579-5588.
63. Leverrier, Y., J. Thomas, A. Mathieu, W. Low, B. Blanquier, and J. Marvel. 1999. Role of P13-kinase in Bc1-X induction and apoptosis inhibition mediated by IL-3 or IGF-1 in Baf-3 cells. Cell Death Differ. 6:290-296.
64. Alessi, D.R., F.B. Caudwell, M. Andjelkovic, B.A. Hemmings, and P. Cohen. 1996. Molecular basis for the substrate specificity of protein kinase B; comparison with MAPKAP kinase-1 and p70 S6 kinase. FEBS Lett. 399:333-338.
65. Downward, J. 1999. How BAD phosphorylation is good for survival. Nat. Cell Biol. 1:E33-E35.
66. Khwaja, A. 1999. Akt is more than just a Bad kinase. Nature. 401:33-34.
67. Kitada, S., M. Krajewska, X. Zhang, D. Scudiero, J.M. Zapata, H.G. Wang, A. Shabiak, G. Tudor, S. Krajewski, T.G. Myers, et al. 1998. Expression and location of pro-apoptotic Bcl-2 family protein BAD in normal human tissues and tumor cell lines. Am. J. Pathol. 152:51-61.
68. Sonenshein, G.E. 1997. Rel/NF-κB transcription factors and the control of apoptosis. Semin. Cancer Biol. 8:113-119.
69. Jamieson, C., P.G. McCafrrey, A. Roa, and R. Sen. 1991. Physiologic activation of T cells via the T cell receptor induces NF-kappa B. J. Immunol. 147:416-420.
70. Parry, R.V., K. Reif, G. Smith, D.M. Sanson, B.A. Hemmings, and S.G. Ward. 1997. Ligation of the T cell co-stimulatory receptor CD28 activates the serine-threonine protein kinase protein kinase B. Eur. J. Immunol. 27:2495-2501.
71. Costello, R., C. Lipcey, M. Algarte, C. Cerdan, P.A. Baeuerle, D. Olive, and J. Imbert. 1993. Activation of primary human T-lymphocytes through CD2 plus CD28 molecules induces long-term nuclear expression of NF-kappa B. Cell Growth Differ. 1993:329-339.
72. Chu, Z.L., T.A. McKinsey, L. Liu, J.J. Gentry, M.H. Malim, and D.W. Ballard. 1997. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control. Proc. Natl. Acad. Sci. USA. 94:10057-10062.
73. Wang, C.Y., M.W. Mayo, R.G. Korneluk, D.V. Goeddel, and A.S. Baldwin, Jr. 1998. NF-kappaD antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science. 281:1680-1683.
74. Zong, W.-X., L.C. Edelstein, C. Chen, J. Bash, and C. Gelinas. 1999. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNFα-induced apoptosis. Genes Dev. 13:382-387.
75. Lee, H.H., H. Dadgostar, Q. Cheng, J. Shu, and G. Cheng. 1999. NF-κB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. Proc. Natl. Acad. Sci. USA. 96:9136-9141.
76. Hettmann, T., J. DiDonato, M. Kann, and J.M. Leiden. 1999. An essential role for nuclear factor κB in promoting double positive thymocyte apoptosis. J. Exp. Med. 189:145-158.